The Infectious Disease Self-Assessment Program provides two releases per year (May and November). The content of these releases will assist the pharmacist in analyzing the latest evidence-based information and in translating that information into patient care to improve outcomes.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

Pharmacists can use IDSAP to develop and assess their knowledge in the science and application of pharmacotherapy. This information can be integrated into structured training programs or assist advanced-level practitioners in maintaining their clinical competence.

The IDSAP Series Editors design each year’s releases by drawing from the domains, tasks, and knowledge statements in the BPS Infectoius Disease Pharmacist Certification Content Outline/Classification System. These two program leaders are:

Series Editor, Elizabeth S. Dodds Ashley, Pharm.D., MHS, BCPS, Associate Professor of Medicine, Division of Infectious Diseases Duke, University School of Medicine, Director of Operations, Duke Antimicrobial Stewardship Outreach Network (DASON) Durham, North Carolina

Series Editor Alan E. Gross, Pharm.D., BCPS, BCIDP, Clinical Assistant Professor, Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Infectious Diseases Pharmacist, Hospital Pharmacy Services, University of Illinois Hospital and Health Sciences System, Chicago, Illinois

Working with a Faculty Panel Chair (guest editor), the Series Editors refine the list of chapters and features so that only the most relevant topics are updated in each release. Members of the faculty panel collaborate on the content outline for each chapter and feature, ensuring a complete review of published evidence on that clinical topic. Generalist BCIDP reviewers join the editorial process to enhance the material’s appropriateness for the recertifying audience. The result is an evidence-based update that can be used to self-assess clinical skills and improve patient outcomes.

Each IDSAP release is an online book made up of peer-reviewed chapters and electronic features covering a specific therapeutic area. Feature formats (either the interactive case or the recorded webcast) will vary by topic to provide the best method of relating information to clinical practice.

Review-style chapters include:

• In-text references to the latest published data
• Full-color photographs, illustrations, and graphics
• Hyperlinks to assessment tools, online resources, and the latest guidelines
• Patient Care Scenarios (practice application exercises)
• Practice Points (the take-home messages)

Interactive cases include:

• In-text references to the latest published data
• Illustrations and graphics
• Hyperlinks to assessment tools, online resources, and the latest guidelines
• Case-based examples that lead to detailed feedback
• Practice Points (the take-home messages)

Recorded webcasts include:

• PowerPoint slides with recorded narrative
• On-slide references to the latest published data
• Photographs, illustrations, and graphics
• Hyperlinks to assessment tools, online resources, and the latest guidelines
• Patient Care Scenarios (practice application exercises)
• Practice Points (the take-home messages)

Self-Assessment Questions are found at the end of each chapter, interactive case, or recorded webcast. These high-level, case-based, multiple-choice questions test application of the material to real-world practice. Explained answers, provided after the close of BCIDP testing, are a vital component of the learning process and include a detailed rationale for each self-assessment question with hyperlinks to citations that support optimal decision-making. For more on ACPE and BCIDP credit from IDSAP, see below.

Once purchased, the current IDSAP release (and any previously released IDSAPs) will appear in your My Account page under My Products. The principal IDSAP release is an online book (interactive PDF) that can be saved to the desktop or printed. The latest version of Adobe Reader (available free) offers functionality such as highlighting or adding “sticky notes” to the text. Intra-document and external links connect you immediately to the information you want and need. As each book is released, it will be automatically added to your My Account page.

An e-media format, provided in addition to the interactive PDF, is perfect for “anywhere, anytime” access. This format allows CardSAP information to be viewed on an e-reader, tablet, iOS or Android smart phone.

For assessment purposes, IDSAP content is grouped into learning modules. Each release consists of 3–4 modules; each module contains 2–3 review-style chapters or 2–3 electronic features. The Self-Assessment Questions in each module are accessed from the My Products section of your My Account page. Please note the following:

• Only completed tests are eligible for credit; no partial or incomplete tests will be processed.
• You may complete one or all available modules for credit.
• Tests may not be submitted more than one time.

BCIDP Recertification Credit:

To be eligible to receive BCIDP recertification credit from an IDSAP module, the required posttest must be submitted within the 6-month period after the book’s release. Test deadlines are listed on the first page of every release. The passing point to earn BCIDP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCIDP test deadline that meets this passing point will earn BCIDP recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCIDP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org. The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs.

Continuing Pharmacy Education (CPE) Credit:

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
 

All IDSAP releases are application-based activities.

To receive ACPE CPE credit for an IDSAP module, a posttest must be submitted within 3 years after the book’s release. Test deadlines are listed on the first page of every release. The passing point to earn ACPE CPE credit for an IDSAP module is 50%. Any posttest submitted before the ACPE deadline that scores 50% or greater will be awarded the appropriate CPE. These credits will be assigned as of the date of test submission and reported within 48 hours. For statements of CPE credit, visit www.mycpemonitor.net.

Posttest answers: The explained answers – with rationale and supporting references – will be posted 2 weeks after the BCIDP test deadline and will be available to anyone who has either (1) submitted a posttest or (2) waived the right to receive credit from a posttest (see below). Explained answers will be posted on the My Products section of the My Account page where posttests are accessed.

Waiving Credits: To access the explained answers without submitting a posttest, sign in to your My Account page, select the IDSAP book, and click on the waiver link for that module. By completing the waiver form for a module, you waive the opportunity to receive CPE credit for that module. After you submit a waiver, you will see a link to the PDF file that contains the answers for the module you waived. Answers will be available starting 2 weeks after the BCIDP test deadline.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this posttest. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

Two IDSAP books are released each year; release dates are in May and November. To be eligible for BCIDP recertification credit, the required posttest must be submitted within 6 months of each book’s release. All IDSAP releases available for purchase are listed below. Note that only the current and future releases have BCIDP recertification opportunities. IDSAP releases that are available for ACPE Only may have a discounted price. Click each title for tables of contents, sample chapters, faculty, and contact hours for each module as they become available.

Purchase IDSAP releases as single books, or buy any three or more in a single transaction and receive savings of 20% off the single-book price. Purchase the entire six-book 2019–2021 series for savings of 40% off the single-book price.

^a Applies to any three or more releases from the same series purchased in the same transaction. Discount will be applied at checkout.

ASHP members, please call (913) 492-3311 to receive member pricing. Your ASHP membership number and expiration date are required.

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The inaugural release in ACCP’s new Infections Diseases Self-Assessment Program (IDSAP) focuses on evidence-based management strategies for a wide range of viral and opportunistic infections commonly seen in patients.

HIV and Hepatitis contains three learning modules with a total available 15.0 continuing pharmacy education (CPE) credits. The book content was developed under the leadership of Faculty Panel Chair Betty J. Dong, Pharm.D., FCCP, FASHP, FAPHA, AAHIVP.

The target audience for this release is pharmacists caring for patients with one or more disorders related to infections from the HIV or hepatitis virus.

Chapters in the first module review the most recent guidelines in the prevention and management of HIV and opportunistic infections. The second module updates readers about the current therapeutics of hepatitis A, B, C, and D infections. Topics in the last module provide interactive case discussions on HIV and hepatitis C drug interactions in addition to a new electronic feature format: a recorded webcast promoting HIV and hepatitis pharmacy services via telemedicine.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3-5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Publisher: ACCP, ASHP; 135 pages, May 2019; ISBN-13: 978-1-939862-85-3

• Release date: May 15, 2019
• BCIDP credit expiration date: November 15, 2019
• ACPE credit expiration date: May 14, 2022
• Target Audience 
• Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The newest release in ACCP’s new Infections Diseases Self-Assessment Program (IDSAP) focuses on evidence-based management strategies for the prevention and management of drug-resistant gram-negative infections.

MDR Gram-Negative Infections contains three learning modules with a total available 13.5 continuing pharmacy education (CPE) credits. The book content was developed under the leadership of Faculty Panel Chair Jason M. Pogue, Pharm.D., BCPS, BCIDP.

These modules are relevant to all board certified infectious diseases pharmacists as strategies to more rapidly and optimally manage resistant Gram-negative infections are paramount to the practice of infectious diseases pharmacotherapy.

The first module of this IDSAP focuses on the Enterobacteriaceae beginning with a comprehensive chapter thoroughly describing resistance mechanisms to different antibacterial classes in these pathogens, as well as key management considerations for different drug-resistance scenarios. This chapter is supplemented by a “deep dive” feature that digs into the clinical controversy assessing carbapenems versus beta-lactam beta-lactamase inhibitors for the management of invasive ESBL infections. The second module shifts the focus to non-fermenters with similar chapters dedicated to P. aeruginosa as well as A. baumannii and S. maltophilia. The IDSAP wraps up in module three with practical chapters for the clinician focusing on strategies to optimize empiric therapy in the era of MDR Gram-negative infections and understanding and applying PK/PD principles in dose selection in order to optimize the probability of success with a chosen antimicrobial regimen for the management of these infections.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3-5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Publisher: ACCP, ASHP; 135 pages, November 2019; ISBN-13: 978-1-939862-95-2

• Release date: November 15, 2019
• ORIGINAL BCIDP credit expiration date: May 15, 2020
• EXTENDED BCIDP credit expiration date: July 10, 2020
• ACPE credit expiration date: November 14, 2022
• Target Audience 
• Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The newest release in ACCP’s new Infections Diseases Self-Assessment Program (IDSAP) focuses on Pharmacokinetics and Pharmacodynamics (PK/PD) of anti-infectives in special populations as well as antimicrobial prophylaxis.

The target audience for PK/PD in Special Populations and Antimicrobial Prophylaxis is Board Certified Infectious Diseases Pharmacists caring for patients with or at risk of infectious diseases.

The book contains three learning modules with a total available 13.5 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair Marc H. Scheetz, Pharm.D., M.Sc., BCPS.

The modules focus on PK/PD in special populations as well as prevention of infectious diseases. In the former, the reader will receive a contemporary overview of PK/PD in critical illness and therapeutic drug monitoring. A dedicated section will give practitioners insight into laboratory methodologies that occur in order to assay drugs. Understanding patient pathophysiology, methods and limitations of drug measurement, and current best practices for therapeutic drug monitoring will equip practitioners to improve care for their patients through precision dosing. The second focus is on prevention of infectious diseases through surgical prophylaxis and adult vaccines. Features in the final module explore how clinical decision-making support can augment clinical acumen and understand the regulatory environment under which drugs are approved.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Publisher: ACCP, ASHP; 135 pages, May 2020; ISBN-13: 978-1-952291-02-9

• Release date: May 15, 2020
• BCIDP credit expiration date: November 16, 2020
• ACPE credit expiration date: May 15, 2023
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Resistant Gram-Positive Infections, the newest release in ACCP’s Infections Diseases Self-Assessment Program (IDSAP) focuses on evidence-based strategies for the management of antibiotic-resistant gram-positive infections.

The book contains four learning modules with a total available 15.5 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair Whitney J. Nesbitt, Pharm.D., BCPS, BCIDP.

The modules are relevant to the practice of all board certified infectious diseases pharmacists caring for patients with infections due to gram-positive bacteria.

The first and second modules of this IDSAP focus on antibiotic-resistant and difficult to treat gram-positive pathogens, including S. aureus, Enterococcus species, penicillin-resistant S. pneumonia, and C. difficile. Chapters within these modules will review resistance mechanisms and optimal treatment strategies associated with each pathogen. The third module of the IDSAP shifts focus to antimicrobial stewardship and the use of rapid diagnostic testing. Additionally, this module will discuss the pharmacokinetic and pharmacodynamics strategies used to optimize patient care in the setting of gram-positive infections. The final module includes interactive cases. The first chapter within the module highlights combination antibiotics for the treatment of S. aureus infections, while the second chapter focuses on the implementation C. difficile diagnostics in clinical practice.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Publisher: ACCP, ASHP; 200 pages, November 2020; ISBN-13: 978-1-952291-13-5

• Release date: November 16, 2020
• BCIDP credit expiration date: May 17, 2021
• ACPE credit expiration date: November 16, 2023
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Infections in Immunocompromised Patients, the newest release in ACCP’s Infections Diseases Self-Assessment Program (IDSAP) focuses on evidence-based strategies for the management of infections in immunocompromised hosts, including solid organ transplant and hematologic malignancy. Additionally, the book contains information on antibiotic allergies and the effectiveness of antimicrobial stewardship in decreasing antimicrobial resistance. The target audience for the book is board-certified infectious diseases pharmacists caring patients with immune compromise and those involved in antimicrobial stewardship.

Infections in Immunocompromised Patients contains three learning modules with a total available 16.0 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair Samuel L. Aitken, Pharm.D., MPH, BCIDP.

The first and second modules of this IDSAP book focus on fungal and viral infections, including Candida, Aspergillosis, cytomegalovirus, and other herpesviruses. Chapters within these modules will the pathogenesis of each infection as well as the most up-to-date treatment and prevention strategies. The second module also includes information on assessment of antibiotic allergies and the link between antimicrobial stewardship and antimicrobial resistance. The third module of the IDSAP shifts focus to case-based discussions of asymptomatic bacteriuria, nocardia and atypical mycobacteria, as well as immunization in immunocompromised hosts.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Publisher: ACCP, ASHP; 200 pages, May 2021; ISBN-13: 978-1-952291-28-9

• Release date: May 17, 2021
• BCIDP credit expiration date: November 22, 2021
• ACPE credit expiration date: May 17, 2024
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures